Your browser doesn't support javascript.
loading
Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?
Solmaz, Serife; Uzun, Ozcan; Acar, Celal; Sevindik, Omur Gokmen; Piskin, Ozden; Ozsan, Hayri Guner; Demirkan, Fatih; Undar, Bulent; Alacacioglu, Ahmet; Ozcan, Mehmet Ali; Alacacioglu, Inci.
  • Solmaz S; Department of Hematology, Bozyaka Education and Research Hospital, Batman, Turkey.
  • Uzun O; Department of Internal Medicine, Batman Education and Research Hospital, Batman, Turkey.
  • Acar C; Department of Hematology, Bozyaka Education and Research Hospital, Batman, Turkey.
  • Sevindik OG; Department of Hematology, Faculty of Medicine, Medipol University, Istanbul, Turkey.
  • Piskin O; Department of Hematology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
  • Ozsan HG; Department of Hematology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
  • Demirkan F; Department of Hematology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
  • Undar B; Department of Hematology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
  • Alacacioglu A; Faculty of Oncology, Katip Çelebi University, Izmir, Turkey.
  • Ozcan MA; Department of Hematology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
  • Alacacioglu I; Department of Hematology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
J Lab Physicians ; 10(4): 363-369, 2018.
Article en En | MEDLINE | ID: mdl-30498304
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2018 Tipo del documento: Article